Cargando…

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees

Due to the rapid global spread of the Omicron (B.1.1.529) variant, efforts to scale up COVID-19 booster vaccination have been improved, especially in light of the increasing evidence of reduced neutralizing antibody (NT Ab) over time in vaccinated subjects. In this study, neutralizing antibody respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anichini, Gabriele, Terrosi, Chiara, Gandolfo, Claudia, Gori Savellini, Gianni, Fabrizi, Simonetta, Miceli, Giovanni Battista, Franchi, Federico, Cusi, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144393/ https://www.ncbi.nlm.nih.gov/pubmed/35632563 http://dx.doi.org/10.3390/vaccines10050808

Ejemplares similares

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine
por: Anichini, Gabriele, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
por: Anichini, Gabriele, et al.
Publicado: (2021)

Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy
por: Anichini, Gabriele, et al.
Publicado: (2020)

Comparative Performance of a New SARS-CoV-2 Rapid Detection System
por: Gori Savellini, Gianni, et al.
Publicado: (2021)

Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream
por: Gandolfo, Claudia, et al.
Publicado: (2022)

Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
por: Gandolfo, Claudia, et al.
Publicado: (2022)

SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells
por: Gori Savellini, Gianni, et al.
Publicado: (2023)

Efficient Inactivation of SARS-CoV-2 and Other RNA or DNA Viruses with Blue LED Light
por: Terrosi, Chiara, et al.
Publicado: (2021)

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID
por: Cusi, Maria Grazia, et al.
Publicado: (2023)

SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity
por: Gori Savellini, Gianni, et al.
Publicado: (2021)

Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion
por: Gori Savellini, Gianni, et al.
Publicado: (2022)

Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation
por: Gori Savellini, Gianni, et al.
Publicado: (2019)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
por: Gandolfo, Claudia, et al.
Publicado: (2021)

Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience
por: Cusi, Maria Grazia, et al.
Publicado: (2021)

Ubiquitin and Not Only Unfolded Domains Drives Toscana Virus Non-Structural NSs Protein Degradation
por: Gori Savellini, Gianni, et al.
Publicado: (2020)

How long can SARS-CoV-2 persist in human corpses?
por: Gabbrielli, Mario, et al.
Publicado: (2021)

Hot Climate and Humidity Do Not Interfere with BA.5 Omicron Spreading
por: Cusi, Maria Grazia, et al.
Publicado: (2023)

Infectious Toscana Virus in Seminal Fluid of Young Man Returning from Elba Island, Italy
por: Matusali, Giulia, et al.
Publicado: (2022)

Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020
por: Cusi, Maria Grazia, et al.
Publicado: (2020)

Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein
por: De Angelis, Marta, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
por: Dapporto, Francesca, et al.
Publicado: (2022)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Human bocavirus detection in an atopic child affected by pneumonia associated with wheezing
por: Terrosi, Chiara, et al.
Publicado: (2007)

Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia
por: Fezaa, Ons, et al.
Publicado: (2014)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation
por: Mileto, D., et al.
Publicado: (2022)

Toscana Virus Epidemiology: From Italy to Beyond
por: Cusi, Maria G, et al.
Publicado: (2010)

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?
por: Piralla, Antonio, et al.
Publicado: (2021)

Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
por: Andreano, Emanuele, et al.
Publicado: (2022)

Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects
por: Cusi, Maria Grazia, et al.
Publicado: (2010)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

RSV and HMPV seroprevalence in Tuscany (Italy) and North‐Rhine Westfalia (Germany) in the winter season 2009/2010
por: Cusi, Maria G., et al.
Publicado: (2011)

Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay
por: Gandolfo, Claudia, et al.
Publicado: (2021)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h3ep9il9hqfe0b4tarpkuq81dj